换一批
换一批Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
第一作者：
M B,Nilsson
第一单位：
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
作者：
主题词
血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);碱性螺旋-环-螺旋转录因子类(Basic Helix-Loop-Helix Transcription Factors);印迹法, 蛋白质(Blotting, Western);细胞运动(Cell Movement);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);流式细胞术(Flow Cytometry);人类(Humans);缺氧诱导因子1, α亚基(Hypoxia-Inducible Factor 1, alpha Subunit);免疫酶技术(Immunoenzyme Techniques);吲哚类(Indoles);小鼠(Mice);小鼠, 近交NOD(Mice, Inbred NOD);小鼠, SCID(Mice, SCID);新生血管化, 病理性(Neovascularization, Pathologic);神经母细胞瘤(Neuroblastoma);原癌基因蛋白质类c-kit(Proto-Oncogene Proteins c-kit);原癌基因蛋白质c-ret(Proto-Oncogene Proteins c-ret);吡咯类(Pyrroles);RNA, 信使(RNA, Messenger);RNA, 小分子干扰(RNA, Small Interfering);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);受体, 血小板源生长因子β(Receptor, Platelet-Derived Growth Factor beta);受体, 白细胞介素2(Receptors, Interleukin-2);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1);血管内皮生长因子受体3(Vascular Endothelial Growth Factor Receptor-3);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1038/onc.2010.60
PMID
20208561
发布时间
2018-12-01
- 浏览8
Oncogene
2938-49页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
